September 6, 2026
Sunday, September 6, 2026
This week: 8 trending tweets, 8 new studies.
New Research
Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA.
EClinicalMedicine
Case report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome.
Medicine
Pharmacist-led medication therapy management improving medication adherence in a patient with type 2 diabetes: case report.
Frontiers in medicine
Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.
Cell reports. Medicine
Metformin-Associated Lactic Acidosis and Relative Euglycemic Ketoacidosis Precipitated by a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report and Literature Review.
Kidney360
Oral Incretin-Based Therapies for Weight Management.
Current atherosclerosis reports
Patulous Eustachian tube dysfunction following rapid weight loss associated with semaglutide use: A case report.
SAGE open medical case reports
Trending on X
Peptide cheat sheet (save this) Recovery & healing BPC-157 (gut lining and soft-tissue repair) TB-500 (muscle, tendon, and injury recovery) KPV (anti-inflammatory, calms the gut) Growth hormone & muscle CJC-1295 + Ipamorelin (GH release, deeper sleep, recovery) Tesamorelin
The deeper I’ve gone into peptides, the more I’ve realized that not every peptide lives up to the hype I’m ranking them based on my experience, what I’ve seen from others, and the research behind them. 1. Fat loss: Retatrutide → Tirzepatide → Semaglutide → AOD-9604. 2.
GET FAMILIAR WITH YOUR PEPTIDE 1. Retatrutide (Reta) One of the peptides I talk about quite a lot because the mechanism is very interesting. → Helps suppress appetite → Supports weight loss → May increase energy expenditure → Supports glucose control → Targets GLP-1 + GIP
Most popular Peptides going into September for research BPC-157 (aids in healing) TB-500 (recovery) Retatrutide (GLP3 weight loss turbo) GLP-1 - Semaglutide & Tirzepatide (weight loss) CJC-1295 and Ipa (growth hormone) Semax & Selank (cognition)
Quality is the moat. Origin is just one data point inside it. https://t.co/v2winTL2KR
If you have an autoimmune condition and you have stalled on retatrutide, tirzepatide or semaglutide while doing everything right, there is a specific mechanism behind it and a specific thing to add. The mechanism: chronic autoimmune inflammation produces elevated TNF-alpha, IL-6
https://t.co/HsKzTEXghe
27.9M Americans had AUD in 2024. 400K+ veterans carry an AUD diagnosis. The VA is testing semaglutide in Phase 3, and @RepNancyMace just introduced the PEPTIDES for Veterans Act. I broke down 14 peptide pathways that could show promise for AUD below. https://t.co/aaiBcvqhWR
Provider Spotlight
MEDVi
MEDvidi is an online mental health treatment center specializing in personalized, affordable telehealth services for conditions such as anxiety, ADHD, depression, and insomnia. They offer compassionate care from licensed medical professionals with a fully digital, human-centered approach.